What is Lifecore Biomedical, Inc.'s operating cash flow?

Lifecore Biomedical, Inc. (LFCR) reported operating cash flow of $4.7M in Q1 2026.

What is the long-term trend for Lifecore Biomedical, Inc.'s operating cash flow?

Over 2 years (2022 to 2024), Lifecore Biomedical, Inc.'s operating cash flow has grown at a -89.3% compound annual growth rate (CAGR), from -$22.59M to $257K.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Lifecore Biomedical, Inc. LFCR Operating Cash Flow

Operating Cash Flow at other companies

Baxter InternationalBAX

$213M+210%

Thermo Fisher ScientificTMO

$1.19B+64.9%

ADMA BiologicsADMA

$58.25M+396%

Medpace Holdings, Inc.MEDP

$151.79M+20.6%

Biodesix, Inc.BDSX

-$10.17M-18.2%

ClearPoint NeuroCLPT

-$7.97M-29.1%

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s operating cash flow?: Lifecore Biomedical, Inc. (LFCR) reported operating cash flow of $4.7M in Q1 2026.
What is the long-term trend for Lifecore Biomedical, Inc.'s operating cash flow?: Over 2 years (2022 to 2024), Lifecore Biomedical, Inc.'s operating cash flow has grown at a -89.3% compound annual growth rate (CAGR), from -$22.59M to $257K.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.